Puma Biotechnology Inc - ESG Rating & Company Profile powered by AI
Alternative corporations in the rating industry group for Puma Biotechnology Inc are displayed below. The analysis of Puma Biotechnology Inc employs information from across the internet as well as from public filings by Puma Biotechnology Inc. The Disclosure rating includes seventeen UN Sustainable Development Goals including: 'Affordable & Clean Energy', 'Reduced Inequalities' and 'Life on Land'.
Puma Biotechnology Inc in the Pharmaceuticals industry gained a UN SDG ESG Transparency Score of 7.3; made up of an environmental score of 8.0, social score of 8.0 and governance score of 6.0.
7.3
High ImpactEnvironmental
Social
Governance
Peer Group Comparison
| Rank | Company | SDG Transparency Score ⓘ | Performance |
|---|---|---|---|
| 1 | Caladrius Biosciences Inc | 8.0 | High |
| 1 | Can Fite Biopharma Ltd | 8.0 | High |
| 160 | YungShin Global Holding Corp | 7.5 | High |
| 160 | Zentiva SA | 7.5 | High |
| 191 | Puma Biotechnology Inc | 7.3 | High |
| 191 | Cellectis SA | 7.3 | High |
| 191 | Aurinia Pharmaceuticals Inc | 7.3 | High |
| ... | ... | ... | |
| 1970 | Zyden Gentec Ltd | 0.0 | Low |
| 1970 | iNtRON Biotechnology Inc | 0.0 | Low |
| ... | ... | ... |
Frequently Asked Questions
Does Puma Biotechnology Inc have an accelerator or VC vehicle to help deliver innovation?
Sign up for free to unlockDoes Puma Biotechnology Inc disclose current and historical energy intensity?
Sign up for free to unlockDoes Puma Biotechnology Inc report the average age of the workforce?
Sign up for free to unlockDoes Puma Biotechnology Inc reference operational or capital allocation in relation to climate change?
Sign up for free to unlockDoes Puma Biotechnology Inc disclose its ethnicity pay gap?
Sign up for free to unlockDoes Puma Biotechnology Inc disclose cybersecurity risks?
Sign up for free to unlockDoes Puma Biotechnology Inc offer flexible work?
Sign up for free to unlockDoes Puma Biotechnology Inc have a long term incentive (LTI) executive compensation plan based on a measure of return on capital?
Sign up for free to unlockDoes Puma Biotechnology Inc disclose the number of employees in R&D functions?
Sign up for free to unlockDoes Puma Biotechnology Inc conduct supply chain audits?
Sign up for free to unlockDoes Puma Biotechnology Inc disclose incidents of non-compliance in relation to the health and safety impacts of products and services?
Sign up for free to unlockIs there a statment that there is no plan to expand their cement production? (for example: 'We have no current plans to add additional cement making capacity')
Sign up for free to unlockDoes Puma Biotechnology Inc conduct 360 degree staff reviews?
Sign up for free to unlockDoes Puma Biotechnology Inc disclose the individual responsible for D&I?
Sign up for free to unlockDoes Puma Biotechnology Inc disclose current and historical air emissions?
Sign up for free to unlockIs there a statment that there is no plan to expand their coal usage? (for example: 'We have no current plans to add additional coal powered electricity generation')
Sign up for free to unlockIs executive remuneration linked to climate performance?
Sign up for free to unlockDoes the Board describe its role in the oversight of climate-related risks and opportunities?
Sign up for free to unlockDoes Puma Biotechnology Inc disclose current and / or historical scope 2 emissions?
Sign up for free to unlockDoes Puma Biotechnology Inc disclose water use targets?
Sign up for free to unlockDoes Puma Biotechnology Inc have careers partnerships with academic institutions?
Sign up for free to unlockDid Puma Biotechnology Inc have a product recall in the last two years?
Sign up for free to unlockDoes Puma Biotechnology Inc disclose incidents of discrimination?
Sign up for free to unlockDoes Puma Biotechnology Inc allow for Work Councils/Collective Agreements to be formed?
Sign up for free to unlockHas Puma Biotechnology Inc issued a profit warning in the past 24 months?
Sign up for free to unlockDoes Puma Biotechnology Inc disclose parental leave metrics?
Sign up for free to unlockDoes Puma Biotechnology Inc disclose climate scenario or pathway analysis?
Sign up for free to unlockDoes Puma Biotechnology Inc disclose current and / or historical scope 1 emissions?
Sign up for free to unlockAre Operating Expesnses linked to emissions reduction?
Sign up for free to unlockDoes Puma Biotechnology Inc disclose the pay ratio of women to men?
Sign up for free to unlockDoes Puma Biotechnology Inc support suppliers with sustainability related research and development?
Sign up for free to unlockDoes Puma Biotechnology Inc disclose the number of operations that have been subject to human rights reviews or human rights impact assessments?
Sign up for free to unlockDoes Puma Biotechnology Inc reflect climate-related risks in its financial statements?
Sign up for free to unlockIs there a statment that there is no plan to expand their carbon intensite energy assets? (for example: 'We have no current plans to carry out further drilling for oil,')
Sign up for free to unlockIs Puma Biotechnology Inc involved in embryonic stem cell research?
Sign up for free to unlockDoes Puma Biotechnology Inc disclose GHG and Air Emissions intensity?
Sign up for free to unlockDoes Puma Biotechnology Inc disclose its waste policy?
Sign up for free to unlockDoes Puma Biotechnology Inc report according to TCFD requirements?
Sign up for free to unlockDoes Puma Biotechnology Inc disclose its policies for bribery, corruption, whistle-blower, conflict of interest?
Sign up for free to unlockDoes Puma Biotechnology Inc disclose energy use targets?
Sign up for free to unlockDoes Puma Biotechnology Inc disclose its Renewable Energy targets?
Subscription requiredAre emissions metrics verified by STBi?
Subscription requiredDoes Puma Biotechnology Inc have a policy relating to cyber security?
Sign up for free to unlockHave a different question?
Potential Risks for Puma Biotechnology Inc
These potential risks are based on the size, segment and geographies of the company.
Puma Biotechnology, Inc., a biopharmaceutical company, focuses on the development and commercialization of products to enhance cancer care in the United States and internationally. The company's drug candidates include PB272 neratinib (oral) for the patients with early stage HER2-overexpressed/amplified breast cancer; PB272 (neratinib, oral) for the use of neratinib in combination with capecitabine for the treatment of adult patients with advanced or metastatic HER2-positive breast cancer; PB272 (neratinib, oral) for HER2 mutation-positive solid tumors. It has a license agreement with Pfizer, Inc.; and sub-license agreement with Specialised Therapeutics Asia Pte Ltd., CANbridge BIOMED Limited, Pint Pharma International SA, Knight Therapeutics, Inc., Pierre Fabre Medicament SAS, and Bixink Therapeutics Co., Ltd. The company was founded in 2010 and is headquartered in Los Angeles, California.